Senior insider sale
CHIEF FINANCIAL OFFICER at MIRUM PHARMACEUTICALS, INC. — senior position signals high conviction
$909.0K
9.76K shares
What this filing means
BJERKHOLT ERIC plans to sell 9.76K shares of MIRUM PHARMACEUTICALS, INC. valued at approximately $909.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001197350-26-000005
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
9.76K
Shares to sell
$909.0K
Approx. market value
7.29K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation for services rendered to Issuer
3/15/2026
7.29KTotal acquired7.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2026 | Restricted Stock Units vesting under registered plan Compensation for services rendered to Issuer | 7.29K | — |
| Total | 7.29K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.05K
Market value
$101.3K
1/26/2026
—Completed
Units to sell
1.42K
Market value
$132.6K
1/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.29K
Market value
$675.1K
3/16/2026
Total
Units
9.76K
Value
$909.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 1.05K | $101.3K | — | Completed |
1/22/2026 | 1.42K | $132.6K | — | Completed |
| Planned — Approximate Date | ||||
3/16/2026 | 7.29K | $675.1K | NASDAQ | Planned |
| Total | 9.76K | $909.0K | ||